DZNE and Intravacc Receive €2.5M EU Funding to Develop Prototype ALS Vaccine

DZNE and Intravacc BV, a leading global contract development and manufacturing organization (CDMO) of preventive and therapeutic vaccines, have received €2.5 million funding from the European Union (EIC Transition Grant) to further develop a prototype ALS vaccine , including process development, upscaling and toxicological research. The project aims to develop the vaccine candidate identified at …

DZNE and Intravacc Receive €2.5M EU Funding to Develop Prototype ALS Vaccine Read More »